Editor’s Choice: Engagement with ERAS patients leads to improved outcomes

Update: 2024-01-29

Description

Editor’s Choice Paper:
Use of a mobile health patient engagement technology improves perioperative outcomes in gynecologic oncology patients

Editorial:
How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs?

Hosted by:
Gregg Nelson, MD, PhD, Social Media Editor of Gynecologic Oncology

Featuring:
Teresa K.L. Boitano, MD, University of Alabama at Birmingham
Kevin M. Elias, MD, FACOG, FACS, Brigham and Women’s Hospital

Comments

In Channel

May 2023 Editor's Choice: Prioritizing and achieving diversity in clinical trial enrollment

2025-09-01--:--

Beyond Anesthesia: Self-Hypnosis in ERAS Programs

2025-08-2924:12

Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

2025-07-1420:25

To divert or not to divert: that is the question

2025-07-0827:38

Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer

2025-03-2716:12

Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study

2025-03-0318:12

Clinical trials: Panacea or pitfall

2025-01-2730:47

FOLR1 status: Landscape beyond high grade serous ovarian cancer

2024-12-3020:26

Benefits of hormonal therapy for low grade serous ovarian cancer

2024-12-3022:40

Implementation and impact of a financial navigation program in gynecologic oncology

2024-10-2332:25

LVSI in Stage 1 Endometrial Cancer

2024-09-2518:19

Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer

2024-09-0231:59

Shifting trends and sicker patients - the future of gynecologic cancer

2024-07-1214:49

2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement

2024-07-0837:08

Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?

2024-04-1513:24

Editor's Choice: Caring for the Caregiver

2024-04-0419:40

Editor’s Choice: Lunchbox Trial

2024-02-2910:18

Editor’s Choice: Engagement with ERAS patients leads to improved outcomes

2024-01-2910:18

October 2023 Editor’s Choice: OS updates for Imagyn50

2023-11-1714:03

September 2023 Editor’s Choice: Is now the time to begin thromboprophylaxis for all patients with advanced ovarian cancer, including those undergoing neoadjuvant chemotherapy?

2023-10-2716:40

00:00

Editor’s Choice: Engagement with ERAS patients leads to improved outcomes

#box-pro-ellipsis-175888429599846{-webkit-line-clamp:2;}Editor’s Choice: Engagement with ERAS patients leads to improved outcomes

Editor’s Choice: Engagement with ERAS patients leads to improved outcomes

Health Advance

Editor’s Choice: Engagement with ERAS patients leads to improved outcomes